Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hanefeld

Showing results (221-230 of 224) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 224 results.
Diabetologia|July 19, 2005
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocolP D Home, S J Pocock, H Beck-Nielsen, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 2009
[Challenge in diabetes therapy: effects of glitazones beyond blood glucose control]G Schernthaner, T Forst, D Gulba, et al.
Lancet (London, England)|September 26, 2006
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, H C Gerstein, S Yusuf, et al.
Diabetologia|March 31, 2010
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisG Schernthaner, A H Barnett, D J Betteridge, et al.
Pageof 23

Showing results (221-230 of 224) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 224 results.
Diabetologia|July 19, 2005
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocolP D Home, S J Pocock, H Beck-Nielsen, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 2009
[Challenge in diabetes therapy: effects of glitazones beyond blood glucose control]G Schernthaner, T Forst, D Gulba, et al.
Lancet (London, England)|September 26, 2006
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, H C Gerstein, S Yusuf, et al.
Diabetologia|March 31, 2010
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisG Schernthaner, A H Barnett, D J Betteridge, et al.
Pageof 23